Managed Account Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Managed Account Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$11.5M	Buy	330,753 +107,453	+48%	+$3.28M	0.01%	1018
2015 Q1	$5.8M	Buy	223,300 +217,174	+3,545%	+$3.98M	0.01%	1363
2014 Q4	$79K	Sell	6,126 -11,579	-65%	-$145K	﹤0.01%	2419
2014 Q3	$217K	Buy	17,705 +4,186	+31%	+$48.6K	﹤0.01%	2306
2014 Q2	$214K	Sell	13,519 -2,992	-18%	-$42.7K	﹤0.01%	2286
2014 Q1	$249K	Buy	+16,511	New	+$186K	﹤0.01%	2203

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Managed Account Advisors's HZNP Position: Q2 2015 in Review

Managed Account Advisors increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 48% in Q2 2015, buying an estimated $3.28M and bringing the position to 330,753 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #1018.

Managed Account Advisors first reported a position in HZNP in Q1 2014 and has held it in 6 quarters since. 213 funds tracked by Wall St. Rank hold HZNP as of Q2 2015.

Managed Account Advisors held 330,753 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $11.5M as of Q2 2015.
Managed Account Advisors bought 107,453 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2015, an estimated $3.28M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1018 holding.
Managed Account Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and has held it in 6 quarters since.
213 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.